PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China; Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing 210008, China.\', \'State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.\', \'Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.\', \'State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China. Electronic address: zhouxd@scu.edu.cn.\', \'State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China. Electronic address: feifeiliyan@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1567-5769(21)00433-110.1016/j.intimp.2021.107797
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 34162159
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
?:title
  • The preparation of N-IgY targeting SARS-CoV-2 and its immunomodulation to IFN-γ production in vitro.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all